ÇÑÀÇ¿ø
ÀÎõÀý¹ÚÀ¯»ê ÇÑÀÇ¿ø ÁÖ¸»Áø·á
#ÀÎõÀý¹ÚÀ¯»ê, #ÀÎõÀý¹ÚÀ¯»êÇÑÀÇ¿ø, #»ý¸®µµº®, #ÀÎõ»ý¸®µµº®, #Àý¹ÚÀ¯»êÇÑÀÇ¿ø, #»ý¸®µµº®ÇÑÀÇ¿ø, #ÀÎõ»ý¸®µµº®, #ÀÎõÀý¹ÚÀ¯»ê ÀÎõÀý¹ÚÀ¯»ê,,ÀÎõÀý¹ÚÀ¯»êÇÑÀÇ¿ø,,»ý¸®µµº®,,ÀÎõ»ý¸®µµº®,,Àý¹ÚÀ¯»êÇÑÀÇ¿ø,,»ý¸®µµº®ÇÑÀÇ¿ø,,ÀÎõ»ý¸®µµº®,,ÀÎõÀý¹ÚÀ¯»ê ¾È³çÇϼ¼¿ä. ÀÎõÀý¹ÚÀ¯»ê ÀÎõ ÇÑÀÇ¿ø ãÀ¸½Ã´Â ºÐµéÀÌ ¸¹À¸½Åµ¥¿ä ÀÎõÀý¹ÚÀ¯»ê ÀÎõ Ä¡·á ãÀ¸½Ã´Â ºÐµéÀÌ ¹Ì¿ÃÇÑÀÇ¿ø ÀÎõÁ¡À» ÀÚÁÖ Ã£À¸½Ã´Âµ¥¿ä. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â»ý¸®µµº®, Ãâ»êÇѾà, ºÒÀÓ¼ö¼ú, »ý¸®ÁõÈıº, ¼¼±Õ¼ºÁú¿°, ºÒ±ÔÄ¢ÇÑ»ý¸®, Æ®¸®Äڸ𳪽ºÁú¿°, È­ÇÐÀûÀ¯»ê¸öÁ¶¸®, È­ÇÐÀûÀ¯»êÈÄÀÓ½Å, ¹«¿ù°æÄ¡·á, Áú°ÇÁ¶Áõ, Æó°æ±âÁõ»ó, »ý¸®ÅëÇѾà, À¯»êÇѾà, ´Þ»ý»ê, ¼ÒÆļö¼ú, 20´ëÀڱñÙÁ¾, »ý¸®ÀüÁõÈıºµÎÅë, °è·ùÀ¯»êÈĸöÁ¶¸®, È­ÇÐÀûÀ¯»êÇÏÇ÷, ³­¼Ò³¶Á¾Ä¡·á, ºÒÀÓÄ¡·á, ¿©¼º¼¼Á¤Á¦, »êÈÄ°ü¸®ÇÑÀÇ¿ø, ÀÚ±ÃÃâÇ÷µî ´Ù¾çÇÑ ¹®ÀǸ¦ ÁÖ°í °è½Ê´Ï´Ù. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â ´Ù¾çÇÑ È¯ÀںеéÀÌ ³»¿øÇÏ°í °è½Ã¸ç °³Àκ° Áõ»ó°ú üÁú¿¡ µû¶ó Áõ·ùÇѾà, Àû¿Ü¼±Ä¡·á, °æÃß°ßÀÎÄ¡·á, µµÀοä¹ý, ¿ªÇÐÄ¡·á, ÆĶóÇÉ¿å, ÀÌ°­·¹ÀÌÀú, ¸ÆÆÄ°Ë»ç, silver spike point, °æÇÇ°æ±ÙÇѳÿä¹ý, À¯ºñ¿À¸ÆÆÄ, Çâ±â¿ä¹ý, NMES, ÀåħÀü±âÀڱؼú, °æ¶ôÇâ±â¿ä¹ý, ±â´ÉÀûÀü±âÀÚ±ØÄ¡·á, ÇѹæÁ¤½Å¿ä¹ý, ¹°¸®Ä¡·á, ¿Â¼º¾îÇ÷¾àħ, Çâ±âÀÚ°¡¿ä¹ý, ¸ÂÃãÇÑ¾à µî ÇÕ¸®ÀûÀÌ°í È¿°úÀûÀÎ ¸ÂÃã Ä¡·á¸¦ Á¦°øÇÏ°í ÀÖ½À´Ï´Ù ¹Ì¿ÃÇÑÀÇ¿øÀº Àü±¹ 20¿©°³ ÁöÁ¡¿¡¼­ Áø·áÁßÀ̸ç Àü³² °íÈﱺ µÎ¿ø¸é, ºÎ»ê µ¿·¡±¸ ¾È¶ô1µ¿, °æ³² ÁøÁֽà Á߾ȵ¿, °æ±â Çϳ²½Ã ÇÏ»ç⵿, ÀÎõ ¼­±¸ ¼®³²3µ¿, ÃæºÏ Á¦Ãµ½Ã ÀǸ²µ¿, °æ±â ¾È¼º½Ã ½Å¸ð»êµ¿, °æºÏ Ä¥°î±º µ¿¸í¸é, °æ³² â¿ø½Ã ¸¶»êÇÕÆ÷±¸ ¼ö¼ºµ¿, Àü³² ¿©¼ö½Ã ºÀ°èµ¿, ÀÎõ ³²±¸ ¿ëÇöµ¿, °æ³² â¿ø½Ã ¼º»ê±¸ »ïÁ¤ÀÚµ¿, ºÎ»ê ±ÝÁ¤±¸ ¼­1µ¿, ÀüºÏ ±èÁ¦½Ã ¹é±¸¸é, Àü³² Áøµµ±º °í±º¸é, ÀüºÏ ±èÁ¦½Ã ºÀ³²¸é, Àü³² ³ªÁֽà ¹®Æò¸é, °­¿ø ÀÎÁ¦±º ±â¸°¸é, °æ±â Àǿսà °íõµ¿, Ãæ³² ±Ý»ê±º Áø»ê¸é, ºÎ»ê »çÇϱ¸ ±«Á¤1µ¿, Àü³² ¹«¾È±º ¸Á¿î¸é, °æ³² â³ç±º °í¾Ï¸é, °æ³² ÇÕõ±º ´ëº´¸é, °æ±â ¾È¼º½Ã µµ±âµ¿, ¿ï»ê ³²±¸ °³¿îµ¿, Àü³² ´ã¾ç±º ´ã¾çÀ¾, Àü³² ³ªÁֽà °ø»ê¸é, ÀÎõ Áß±¸ ¼±¸°µ¿, °æ³² ÇÕõ±º ´ëº´¸é, µî ´Ù¾çÇÑ Áö¿ª Áֹε鲲¼­ ³»¿øÇÏ°í °è½Ê´Ï´Ù ÀÎõÀý¹ÚÀ¯»êÄ¡·á ãÀ¸½Ã´Â µ¿±¸, ¿µÁ¾µµ, µµ¸²µ¿, ¼­Ã¢µ¿, ¼±Çе¿, Á¤¿Õµ¿, ¹®Çе¿, ¼Û¿ùµ¿, ¼Û¸²µ¿, ¼þÀǵ¿, ÀÎõ³íÇö, ¿Á·Ãµ¿, ¼Û»ê¸é, ºñºÀ¸é, ¿¬¼öµ¿, ±¸¿ùµ¿, °è¾ç±¸, °Ë´Ü, °¡Áµ¿, Á־ȿª, ¼Ûµµ½Åµµ½Ã, ³²¾çÀ¾, ÀÎõ¼­±¸, Áß±¸, ¼Ûµµ±¹Á¦µµ½Ã, ¸¸¼öµ¿, »óµ¿, ¿î³²µ¿, ºÎõ, ¼®³²µ¿, ¸Å¼Û¸é, ´ëºÎµµ, ¸¶µµ¸é, °ü±³µ¿, ÆÈź¸é µî ÀÎõ Áö¿ª Áֹε鲲¼­ ¹Ì¿ÃÇÑÀÇ¿øÀÎõÁ¡À» ¹æ¹®ÇÏ°í °è½Ê´Ï´Ù. ´õ »ìÆ캸±â 1. Steed H, Chapman W, Laframboise S. Endometriosis-associated ovarian cancer: a clinicopathologic review. J Obstet Gynaecol Can 2004; 26:709. 2. Gupta D, Hull ML, Fraser I, et al. Endometrial biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev 2016; 4:CD012165. 3. Murphy AA, Green WR, Bobbie D, et al. Unsuspected endometriosis documented by scanning electron microscopy in visually normal peritoneum. Fertil Steril 1986; 46:522. 4. Klenov VE, Potretzke TA, Sehn JK, Thaker PH. Postmenopausal Invasive Endometriosis Requiring Supralevator Pelvic Exenteration. Obstet Gynecol 2015; 126:1215. 5. Escobar-Morreale HF, Botella-Carretero JI, Alvarez-Blasco F, et al. The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery. J Clin Endocrinol Metab 2005; 90:6364. 6. Blanco RG, Parithivel VS, Shah AK, et al. Abdominal wall endometriomas. Am J Surg 2003; 185:596. 7. Brettenthaler N, De Geyter C, Huber PR, Keller U. Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2004; 89:3835. 8. Husby GK, Haugen RS, Moen MH. Diagnostic delay in women with pain and endometriosis. Acta Obstet Gynecol Scand 2003; 82:649. 9. Moghetti P, Castello R, Negri C, et al. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab 2000; 85:139. 10. Norman RJ, Wu R. The potential danger of COX-2 inhibitors. Fertil Steril 2004; 81:493.
  • ÃßõÇϱâ
Tip. ¸Þµð¾÷Àº Àü±¹ÀÇ º´ÀÇ¿ø(¾à±¹) Á¤º¸¿Í °Ç°­Á¤º¸, Áúº´Á¤º¸ µîÀ» ¾È³»ÇÕ´Ï´Ù.
¡å
ÀÛ¼ºÀÚ   ºñ¹Ð¹øÈ£
 
ÇÑÀÇ¿ø ÁÖ°£º£½ºÆ®
Á¦¸ñ

±¸¹Ì ´ÙÀ̾îÆ®, ±¸¹Ì ÇÑ¹æ ´ÙÀ̾îÆ® ¸¼Àº½£ÇÑÀÇ¿ø

¾È³çÇϼ¼¿ä. ±¸¹Ì ´ÙÀ̾îÆ® ÇÑÀÇ¿ø ¸¼Àº½£ÇÑÀÇ¿øÀÔ´Ï´Ù. ¿À´ÃÀº ´ÙÀ̾îÆ®¿¡ °ü½ÉÀִ ȯÀںе鿡°Ô ÁÁÀº(!) ¼Ò½ÄÀ» µé°í ¿Ô´Âµ¥¿ä^¤Ñ^2020³âºÎÅÍ ±¸¹Ì¸¼Àº½£ÇÑÀÇ¿ø¿¡¼­ ½î¿Á´ÙÀ̾îÆ®¸¦ ·±

Ãßõ¼ö : 0 , Á¶È¸¼ö : 8,809 , ´ñ±Û¼ö : 0

ÀÚÀ±ÇÑÀÇ¿ø ¼­ÃÊÁ¡ 4¿ù À̺¥Æ® ¾È³»ÇØ¿ä

¾È³çÇϼ¼¿ä. ÀÚÀ±¼­ÃÊÁ¡ ÀÔ´Ï´Ù¾î´Àµ¡ º½ÀÌ ¼ºÅ­ ´Ù°¡¿ÍÀÚÀ±¼­ÃÊÁ¡ ¿¡¼­´Â º½¸ÂÀÌ À̺¥Æ®¸¦ Áغñ ÇÏ¿´¾î¿ä ¿¬·É°íº»´Ü ¡é³ëÈ­¹æÁö, º½Ã¶ È°·ÂÃæÀü¸¸¼ºÇÇ·Î ÇؼÒ, ¼º±â´É °­È­Ä¡¸Å ¹× °Ç¸ÁÁõ

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,708 , ´ñ±Û¼ö : 0

±¤ÁÖºñ¿° Ä¡·á ÀßÇϴ°÷ Ãßõ °æÈñ´ÜºñÇÑÀÇ¿ø

±¤ÁÖºñ¿° Ä¡·á ÀßÇϴ°÷ Ãßõ!!! °æÈñ´ÜºñÇÑÀÇ¿ø ¡Ú 365ÀÏ ºñ¿°À» ´Þ°í»ç´Â ¿ì¸® ³²µ¿»ý ¤Ì¤Ì±º´ë°¬À»¶§ ¿ÀÈ÷·Á ½ÉÇØÁúÁÙ ¾Ë¾Ò´Âµ¥, ¿ÀÈ÷·Á±ÔÄ¢ÀûÀÎ »ýÈ°À» ÇÏ´Â ±º´ë¿¡¼­´Â ¿ÀÈ÷·Á ÁÁ¾Æ

Ãßõ¼ö : 8 , Á¶È¸¼ö : 22,416 , ´ñ±Û¼ö : 0

ÇØÀ² È«´ë¿©µå¸§ÇÑÀÇ¿ø 2021³â 4¿ù °¡°Ý À̺¥Æ® ¾È³»

ÇØÀ²ÇÑÀÇ¿ø È«´ëÁ¡ 2021³â 4¿ù °¡°Ý À̺¥Æ® ¾È³»​¾È³çÇϼ¼¿ä ÇØÀ²ÇÑÀÇ¿ø È«´ëÁ¡ ¿øÀå Á¤ÁÖ¿µ 2021³â 4¿ùÀ» ¸Â¾Æ ±ÛÀ» ¿Ã¸³´Ï´Ù^^​¾î±è¾øÀÌ ¸Å¿ùÀÌ ¹Ù²ð

Ãßõ¼ö : 0 , Á¶È¸¼ö : 6,126 , ´ñ±Û¼ö : 0

ºñ¸¸Ä¡·áÇÑÀÇ¿ø Ãßõ

ºñ¸¸ÇÑÀÇ¿ø¿¡¼­ µþ¾ÆÀÌ °ü¸®Á» ¹Þ°ÔÇÏ°í ½ÍÀºµ¥ Á» ÇØÁÖ¼¼¿ä.ã¾Æº¸´Ï±î ºñ¸¸Ä¡·á ÀßÇÏ´Â ÇÑÀÇ¿øµµ ²Ï µÇ´Â°Å °°´øµ¥...¾îµð°¡ ÀßÇϳª¿ä?ã¾Æº¸´Ï ÇÑÀÇ¿ø¿¡¼­ Çϸé üÁú°³¼±´ÙÀ̾îÆ®°¡ µÇ¼­

Ãßõ¼ö : 0 , Á¶È¸¼ö : 6,960 , ´ñ±Û¼ö : 1